My Account Log in

4 options

Expanding access to investigational therapies for HIV infection and AIDS : March 12-13, 1990, conference summary / Eve Nichols [writer] ; Roundtable for the Development of Drugs and Vaccines against AIDS, Institute of Medicine.

EBSCOhost Academic eBook Collection (North America) Available online

View online

Ebook Central Academic Complete Available online

View online

NCBI Bookshelf Available online

View online

National Academies Press Available online

View online
Format:
Book
Author/Creator:
Nichols, Eve K.
Contributor:
Roundtable for the Development of Drugs and Vaccines against AIDS (Institute of Medicine)
Language:
English
Subjects (All):
AIDS (Disease)--Chemotherapy--Social aspects--United States--Congresses.
AIDS (Disease).
Pharmacology, Experimental--Social aspects--United States--Congresses.
Pharmacology, Experimental.
HIV infections--Chemotherapy--Social aspects--United States--Congresses.
HIV infections.
Physical Description:
1 online resource (83 p.)
Edition:
1st ed.
Place of Publication:
Washington, D.C. : National Academy Press, 1991.
Language Note:
English
Summary:
The call for a "parallel track" for AIDS drug development--a proposal that would allow the early distribution of AIDS drugs to large numbers of patients in parallel with the conventional clinical trials that assess the drugs' safety and efficacy--has sparked controversy within the scientific community. Questions have arisen about the risks to patients of such a plan, about its potential effect on the successful completion of standard controlled trials, and about whether the parallel track will generate useful data. Larger questions have also been raised about whether the parallel track heralds fundamental changes in the philosophy underlying drug regulation in the United States, about the costs and financing of investigational therapies and associated medical costs, and about the role of expanded access mechanisms for drugs in reaching those whose health care is generally inadequate. This volume summarizes a conference hosted by the Institute of Medicine that illuminated these issues.
Contents:
Expanding Access to Investigational Therapies for HIV Infection and AIDS
Copyright
PREFACE
Contents
EXPANDING ACCESS TO INVESTIGATIONAL THERAPIES FOR HIV INFECTION AND AIDS
Expanding Access to Investigational Therapies March 12-13, 1990 Program
1 HISTORICAL PERSPECTIVE
EARLY DEVELOPMENT OF EXPANDED ACCESS
Drug Amendments of 1962
Access for Therapeutic Purposes
Growing Confusion
Modern Clinical Trials (Non-AIDS Drugs)
THE ADVENT OF AIDS
Broadening Participation
Accelerating the Pace of Drug Development
Improving Response Capabilities
Expedited Development
Expanded Access
Treatment Investigational New Drugs
Parallel Track
2 RIGHTS AND RESPONSIBILITIES
FREEDOM OF CHOICE
INFORMED CONSENT
Information Resources
Access
Primary Care
Difficult Choices
COMPETING RIGHTS
INSTITUTIONAL REVIEW BOARDS
NEW ATTITUDES
3 EVALUATION OF EXPANDED ACCESS PROGRAMS
TREATMENT INVESTIGATIONAL NEW DRUGS
POTENTIAL RISKS
Examples from the Past
The Target Population
Safety Data
IMPACT ON CONVENTIONAL RANDOMIZED TRIALS
THE PARALLEL TRACK EXPERIMENT
4 CREATIVITY IN CLINICAL TRIALS
THE CHANGING ENVIRONMENT
CONVENTIONAL TRIALS
PREFERENCE TRIALS
LARGE, SIMPLE RANDOMIZED TRIALS
Physician Participation
Quality Control
DATA FROM THE PARALLEL TRACK
Efficacy Data
Safety Data and Related Information
Expectations
5 DRUG INNOVATION AND THE PHARMACEUTICAL INDUSTRY
TIME TO COMMERCIALIZATION
DIRECT COSTS OF EXPANDED ACCESS
Manpower Needs
Drug Costs
The Small Manufacturer
PRODUCT LIABILITY
Concerns Specific to the Parallel Track
Potential Solutions
6 THIRD-PARTY PAYERS
BLUE CROSS AND BLUE SHIELD
HEALTH INSURANCE ASSOCIATION OF AMERICA
HEALTH CARE FINANCING ADMINISTRATION
Medicaid
State Discretion.
Patient Care Costs
Medicare
RESOURCES FOR CLINICAL INVESTIGATION
7 IMPROVING ACCESS TO CARE
PEOPLE OF COLOR
Resource Considerations
Suspicion
Informed Consent
WOMEN
The Gender Perspective
Risk Factors
Protocol Development
Women as Vectors
A New Approach
THE PEDIATRIC POPULATION
Scientific Issues
Social Issues.
Notes:
Bibliographic Level Mode of Issuance: Monograph
Includes bibliographical references.
ISBN:
9786610203567
9781280203565
1280203560
9780309583367
0309583365
9780585155470
058515547X
OCLC:
559734779

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Library Catalog Using Articles+ Library Account